bibliographic entry 9455885 [be/9455885]
https://w3id.org/oc/corpus/be/9455885

is a

• bibliographic reference

content

• Vey N, Bourhis J, Boissel N, Bordessoule D, Prebet T, et al (2012) A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission. Blood 120: 4317–4323. doi: 10.1182/blood-2012-06-437558 PMID: 23002117

references

• https://w3id.org/oc/corpus/br/1912384